Merck and Eisai report mixed results from LEAP-015 trial of Keytruda and Lenvima in HER2-negative gastroesophageal cancer treatment.

Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $113 from $123 and keeps an Equal Weight rating on the ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other long-term stock picks. Prem Watsa is a Canadian billionaire, entrepreneur ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

President Bush successfully urged Congress to require the substitution of high-octane ethanol for toxic gasoline carcinogens, preferred by the petroleum industry since they are made from oil — a ...

After hours: 7:59:30 p.m. EST Loading Chart for MRK ...

Purpose: The chemical interactions that cause drug incompatibility in solutions, with emphasis on the acid-base and ionized-nonionized forms of organic, weak, electrolyte drugs, are examined ...

The net NPA ratio at 0.53% came in from 0.79% as in September 2024 and 0.80% at the end of December 2023.

Pre-Market: 8:28:01 a.m. EST ...